Clinical trials underrepresent women, children, and adults aged 65 years or older, so diabetes guidelines must be adapted to ...
Al-Gahtani, S. (2026) Review of Literature Investigating the Correlation between Prevalence of Risk Factors Associated with ...
Dr. Nassir Marrouche is director of the Heart and Vascular Institute at Tulane University with a subspecialty in ...
Objectives Given the rapidly evolving therapeutic landscape for type 2 diabetes (T2D) and chronic kidney disease (CKD), this study aimed to characterise the clinical profiles and real-world outcomes ...
Our top 5 heart failure articles of 2025 include FDA approvals, improving guideline-directed medical therapy (GDMT), markers ...
There is increasing evidence that gum disease is associated with increased risk of cardiovascular events, including heart ...
Bayer receives Japanese approval for finerenone to treat patients with chronic heart failure: Berlin Tuesday, December 23, 2025, 14:00 Hrs [IST] Bayer announced that Japan’s Min ...
Officials for the FDA have expanded its’ approval of pimobendan chewable tablets (Vetmedin; Boehringer Ingelheim) to include ...
"HCM is a heart muscle disease associated with a significant symptom burden. This approval of a new drug, Myqorzo, represents ...
14d
Study finds normalising blood glucose with lifestyle could halve heart disease risk in prediabetics
A study reveals that normalizing blood glucose in prediabetics can significantly reduce heart disease risk and mortality ...
Cytokinetics announced the FDA approval of aficamten to improve functional capacity and symptoms in adults with symptomatic obstructive hypertrophic cardiomyopathy.The agency approved 5 mg, 10 mg, 15 ...
The American College of Cardiology (ACC) and the American Heart Association, along with several other leading medical associations, have issued a new guideline for managing congenital heart disease in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback